Kestra Medical Technologies (KMTS) Return on Sales (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Return on Sales data on file, last reported at 0.03% in Q2 2026.

• On a quarterly basis, Return on Sales rose 5.0% year-over-year to 0.03% in Q2 2026; TTM through Apr 2026 was 0.0%, a 2.0% increase from a year earlier, with the FY2026 full-year figure at 0.0%, up 2.0% from the prior year.
• Return on Sales for Q2 2026 stood at 0.03%, up from 0.01% in the prior quarter.
• Over the last five years, Return on Sales for KMTS reached as high as 0.03% in Q2 2026 and fell as low as 0.03% in Q2 2025.
• Historically, Return on Sales has averaged 0.01% across 3 years, with a median of 0.01% in 2025.
• Across the five-year window, Return on Sales fell 1 bps in 2025 and gained 5 bps in 2026, its largest moves.
• Year by year, Return on Sales stood at 0.01% in 2024, then slipped by 4 bps to 0.01% in 2025, then soared by 286 bps to 0.03% in 2026.
• Per Business Quant data, the three most recent Return on Sales figures were 0.03% in Q2 2026, 0.01% in Q1 2026, and 0.01% in Q4 2025.